Abstract:Autism spectrum disorder (ASD) is a neurodevelopmental disorder with high genetic heritability but heterogeneity. Fully understanding its genetics requires whole-genome sequencing (WGS), but the ASD studies utilizing WGS data in Chinese population are limited. In this study, we present a WGS study for 334 individuals, including 112 ASD patients and their non-ASD parents. We identified 146 de novo variants in coding regions in 85 cases and 60 inherited variants in coding regions. By integrating these variants with an association model, we identified 33 potential risk genes (P<0.001) enriched in neuron and regulation related biological process. Besides the well-known ASD genes (SCN2A, NF1, SHANK3, CHD8 etc.), several high confidence genes were highlighted by a series of functional analyses, including CTNND1, DGKZ, LRP1, DDN, ZNF483, NR4A2, SMAD6, INTS1, and MRPL12, with more supported evidence from GO enrichment, expression and network analysis. We also integrated RNA-seq data to analyze the effect of the variants on the gene expression and found 12 genes in the individuals with the related variants had relatively biased expression. We further presented the clinical phenotypes of the proband carrying the risk genes in both our samples and Caucasian samples to show the effect of the risk genes on phenotype. Regarding variants in non-coding regions, a total of 74 de novo variants and 30 inherited variants were predicted as pathogenic with high confidence, which were mapped to specific genes or regulatory features. The number of de novo variants found in patient was significantly associated with the parents' ages at the birth of the child, and gender with trend. We also identified small de novo structural variants in ASD trios. The results in this study provided important evidence for understanding the genetic mechanism of ASD.

De novo genic mutations among a Chinese autism spectrum disorder cohort

Autism Spectrum Disorder Early in Development Associated with CHD8 Mutations among Two Chinese Children

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Genome-wide characteristics of de novo mutations in autism

Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation

Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected families

The contribution of de novo coding mutations to autism spectrum disorder

Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders

Genomic Landscapes of Chinese Sporadic Autism Spectrum Disorders Revealed by Whole-Genome Sequencing.

Patterns and rates of exonic de novo mutations in autism spectrum disorders

Whole-genome sequencing identifies novel genes for autism in Chinese trios

De Novo Variants in Chinese ASD Trios Reveal Distinct Genetic Basis Underlying Autism with and Without Developmental Delay

Identification of De Novo Mutations in the Chinese Autism Spectrum Disorder Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

De Novo Insertions and Deletions of Predominantly Paternal Origin Are Associated with Autism Spectrum Disorder.

Noncoding de novo mutations in are associated with autism spectrum disorders

Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort

Discovery and Validation of Novel Genes in a Large Chinese Autism Spectrum Disorder Cohort.

Two de novo variations identified by massively parallel sequencing in 13 Chinese families with children diagnosed with autism spectrum disorder.

Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder

Rates of contributory de novo mutation in high and low-risk autism families